Advanced Filter

Filter by Group

Filter by Market Availability

Displaying drugs 601 - 625 of 983 in total
Dalcetrapib is under investigation for the treatment of Acute Coronary Syndrome.
Investigational
Matched Categories: … Sulfur Compounds …
SB-269970 is an experimental drug developed by GlaxoSmithKline. In the studies performed with this agent, it has been suggested that SB-269970 acts either as a selective antagonist or inverse agonist of the serotonin receptor 7 (5-HT7).[A31816,A31817]
Investigational
Matched Categories: … Sulfur Compounds …
Experimental
Matched Categories: … Sulfur Compounds …
Azemiglitazone is under investigation in clinical trial NCT01280695 (A Randomized, Double-blind, Comparator- and Placebo-controlled, Multiple-dose Study to Evaluate the Safety, Tolerability and Efficacy of Three Dose Levels of MSDC-0602 in Type 2 Diabetic Patients).
Investigational
Matched Categories: … Sulfur Compounds …
Experimental
Matched Categories: … Sulfur Compounds …
INCB13739 is developed as a new treatment for type 2 diabetes. It is an orally available small molecule inhibitor of 11beta-HSD1 (11-beta hydroxysteroid dehydrogenase type 1). 11beta-HSD1 is an enzyme that appears to be critical to the development of type 2 diabetes.
Investigational
Matched Categories: … Sulfur Compounds …
Ertiprotafib belongs to a novel class of insulin sensitizers developed for treatment of type 2 diabetes. In insulin-resistant rodent models, ertiprotafib and a close analog lowered both fasting blood glucose and insulin levels and improved glycemic excursion during an oral glucose tolerance test.
Investigational
Matched Categories: … Sulfur Compounds …
Fasiglifam has been used in trials studying the treatment of Chronic Kidney Disease, Type 2 Diabetes Mellitus, and Diabetes Mellitus, Type 2.
Investigational
Matched Categories: … Sulfur Compounds …
Intepirdine has been used in trials studying the treatment of Alzheimer's Disease.
Investigational
Matched Categories: … Sulfur Compounds …
Experimental
Matched Categories: … Sulfur Compounds …
Calcium plays a vital role in the anatomy, physiology and biochemistry of organisms and of the cell, particularly in signal transduction pathways. The skeleton acts as a major mineral storage site for the element and releases Ca2+ ions into the bloodstream under controlled conditions. Circulating calcium is either in the...
Nutraceutical
Matched Mixtures name: … Calcium Magnesium Sulfur Silicon - Tab …
Experimental
Matched Categories: … Sulfur Compounds …
Nesbuvir has been investigated for the treatment of Hepatitis C.
Investigational
Matched Categories: … Sulfur Compounds …
PF-4191834 has been investigated for the basic science of Asthma.
Investigational
Matched Categories: … Sulfur Compounds …
GLPG0187 has been used in trials studying the treatment of Solid Tumors.
Investigational
Matched Categories: … Sulfur Compounds …
E7820 has been investigated for the treatment of Colon Cancer and Rectal Cancer.
Investigational
Matched Categories: … Sulfur Compounds …
Nepicastat has been investigated for the treatment of Cocaine Dependence and Posttraumatic Stress Disorder.
Investigational
Matched Categories: … Sulfur Compounds …
Experimental
Matched Categories: … Sulfur Compounds …
Experimental
Matched Categories: … Preparations Containing Sulfur
Experimental
Matched Categories: … Amino Acids, Sulfur ... Sulfur Compounds …
KW-7158 is a tricyclic compound with a non-cholingergic mechanism of action for the treatment of "urinary urgency," "frequent urination" and "urinary incontinence" associated with bladder overactivity (involuntary abnormal contraction of the bladder). The therapeutic effects of KW-7158 in overactive bladder may be due to the activation of A-type K(+) channels...
Investigational
Matched Categories: … Sulfur Compounds …
GW274150 has been used in trials studying the treatment and prevention of Asthma, Migraine, Migraine Disorders, and Arthritis, Rheumatoid.
Investigational
Matched Categories: … Sulfur Compounds …
Navitoclax has been used in trials studying the treatment and basic science of Solid Tumors, Non-Hodgkin's Lymphoma, EGFR Activating Mutation, Chronic Lymphoid Leukemia, and Hematological Malignancies, among others. Navitoclax is an orally bioavailable small molecule inhibitor of Bcl-2 family proteins. It is a substance being studied in the treatment of...
Investigational
Matched Categories: … Sulfur Compounds …
Pittsburgh Compound B is under investigation in clinical trial NCT01723553 (Amyloid-related Imaging Abnormalities (Microbleeds) in Atypical AD).
Investigational
Matched Categories: … Sulfur Compounds …
Experimental
Matched Categories: … Sulfur Compounds …
Displaying drugs 601 - 625 of 983 in total